Table 4 Survival in antineutrophil cytoplasm antibody associated vasculitides (AAV)
TimeWGMPACSS
12 months85–97% (data from six studies including 398 patients)9 21 22 444682–92% (data from four studies including 252 patients)454893–94% (data from two studies including 155 patients)48 49
24 months86–97% (data from two studies including 263 patients)21 50NANA
60 months69–91% (data from seven studies including 427 patients)5 9 4446 50 5145–76% (data from five studies including 217 patients)4 4547 5160–97% (data from five studies including 187 patients)2 49 5254
120 months75–88% (data from two studies including 211 patients)9 21NANA
  • CSS, Churg–Strauss syndrome; MPA, microscopic polyangiitis; NA, not available; WG, Wegener granulomatosis.